Maurizio Zazzi

Maurizio Zazzi

Università degli Studi di Siena

H-index: 45

Europe-Italy

About Maurizio Zazzi

Maurizio Zazzi, With an exceptional h-index of 45 and a recent h-index of 27 (since 2020), a distinguished researcher at Università degli Studi di Siena, specializes in the field of Virology.

His recent articles reflect a diverse array of research interests and contributions to the field:

In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project

Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes

Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino [1, 2, 4] triazolo [1, 5-a] pyrimidines

A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine

Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy

Prevalence and Characterization of Resistance Profiles of “Unusual” HCV Subtypes in Italy within the Italian Resistance Network Vironet C

Cohort profile: Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression

Maurizio Zazzi Information

University

Position

Professor of Microbiology

Citations(all)

8034

Citations(since 2020)

3130

Cited By

6002

hIndex(all)

45

hIndex(since 2020)

27

i10Index(all)

183

i10Index(since 2020)

89

Email

University Profile Page

Università degli Studi di Siena

Google Scholar

View Google Scholar Profile

Maurizio Zazzi Skills & Research Interests

Virology

Top articles of Maurizio Zazzi

Title

Journal

Author(s)

Publication Date

In-hospital mortality during the wild-type, alpha, delta, and omicron SARS-CoV-2 waves: a multinational cohort study in the EuCARE project

The Lancet Regional Health–Europe

Pontus Hedberg

Milosz Parczewski

Karol Serwin

Giulia Marchetti

Francesca Bai

...

2024/3/1

Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes

The Journal of Infectious Diseases

Federica Giammarino

Adolfo de Salazar

Isabelle Malet

Laura Viñuela

Ana Fuentes

...

2024/1/11

Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino [1, 2, 4] triazolo [1, 5-a] pyrimidines

Organic & Biomolecular Chemistry

Martina Pacetti

Maria Chiara Pismataro

Tommaso Felicetti

Federica Giammarino

Anna Bonomini

...

2024

A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine

AIDS

Diego Ripamonti

Stefano Rusconi

Maurizio Zazzi

2024/2/1

Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy

Molecules

Silvia Cesarini

Ilaria Vicenti

Federica Poggialini

Silvia Filippi

Eleonora Mancin

...

2024/3/24

Prevalence and Characterization of Resistance Profiles of “Unusual” HCV Subtypes in Italy within the Italian Resistance Network Vironet C

Digestive and Liver Disease

O El Khalili

C Chenwi

VC Di Maio

M Alkhatib

E Teti

...

2024/2/1

Cohort profile: Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

BMJ Open

Tommaso Clemente

Laura Galli

Riccardo Lolatto

Roberta Gagliardini

Filippo Lagi

...

2024

Low‐level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression

HIV medicine

S Elén

P Björkman

M Zazzi

M Böhm

E Bernal

...

2024/1

Lower aids-related hospitalizations in women living with HIV multidrug resistance

AIDS

Rebecka Papaioannu Borjesson

Laura Galli

Riccardo Lolatto

Barbara Menzaghi

Marcello Feasi

...

2024/3/1

In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B. 1 and BQ. 1.1 SARS-CoV-2 Viral Variants

Viruses

Lia Fiaschi

Camilla Biba

Ilenia Varasi

Niccolò Bartolini

Chiara Paletti

...

2024/1/23

Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors

BMJ open

Tommaso Clemente

Laura Galli

Riccardo Lolatto

Roberta Gagliardini

Filippo Lagi

...

2024/2/1

PRESTIGIO RING:" An 80-year-old man living with HIV resistant to all four antiretroviral classes and desiring treatment simplification".

The new Microbiologica

Maria Mazzitelli

Maurizio Zazzi

Giulia Marchetti

Vincenzo Spagnuolo

Maria Mercedes Santoro

...

2024/1/1

Efficacy of Lamivudine plus Dolutegravir versus Dolutegravir-based Three-drugs Regimens in Virologically-suppressed People Living with HIV

Open Forum Infectious Diseases

Alberto Borghetti

Arturo Ciccullo

Francesca Lombardi

Diana Giannarelli

Rosa Anna Passerotto

...

2024/4/10

SARS-CoV-2 neutralizing antibodies to B. 1 and to BA. 5 variant after booster dose of BNT162b2 vaccine in HIV patients COVID-Naïve and on successful antiretroviral therapy

Vaccines

Ilaria Vicenti

Monica Basso

Nicole Pirola

Beatrice Bragato

Maria Cristina Rossi

...

2023/4/20

A graph neural network-based model with Out-of-Distribution Robustness for enhancing Antiretroviral Therapy Outcome Prediction for HIV-1

arXiv preprint arXiv:2312.17506

Giulia Di Teodoro

Federico Siciliano

Valerio Guarrasi

Anne-Mieke Vandamme

Valeria Ghisetti

...

2023/12/29

Nucleoside Derivatives of 2, 6‐Diaminopurine Antivirals: Base‐Modified Nucleosides with Broad‐Spectrum Antimicrobial Properties

ChemMedChem

Maria Grazia Martina

Federica Giammarino

Ilaria Vicenti

Elisabetta Groaz

Jef Rozenski

...

2023/8/15

Synthetic Health-related Longitudinal Data with Mixed-type Variables Generated using Diffusion Models

Nicholas IH Kuo

Federico Garcia

Anders Sonnerborg

Michael Bohm

Rolf Kaiser

...

2023/11/30

Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage

Acta Tropica

Serena Marchi

Filippo Dragoni

Adele Boccuto

Olubukola T Idoko

Maurizio Zazzi

...

2023/1/1

Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO registry

International Journal of Antimicrobial Agents

Francesco Saladini

Federica Giammarino

Franco Maggiolo

Micol Ferrara

Giovanni Cenderello

...

2023/3/1

Inflammation burden score in multidrug-resistant HIV-1 infection

Journal of Infection

Tommaso Clemente

Roberta Caccia

Laura Galli

Andrea Galli

Andrea Poli

...

2023/5/1

See List of Professors in Maurizio Zazzi University(Università degli Studi di Siena)